Wednesday, November 18, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

research-retractions

14 stories tagged "research-retractions"

Investigations

PubPeer Comments Ran a Median of 10 Months Ahead of Retractions. Cassava Answered Its Critics With a Lawsuit.

Retracted papers drew comments on PubPeer a median of 10 months before journals pulled them. The Cassava file shows what can happen to the people doing the commenting, and how much of the institutional record never becomes public.

Investigations

Elsevier Has Spent 11 Months on a Plagiarism Complaint Without Posting an Expression of Concern

A Bangladeshi forest study and a Chinese soil study report identical mean incomes for identical stakeholder groups. The authors asked to retract in December 2025. Elsevier's own policy provides for a warning notice, and none is on record.

Investigations

Bioengineered Retracted 119 Papers in October, and Taylor & Francis Answered With a 16-Month-Old Note

More than 1,000 papers in one Taylor & Francis journal carry an "under investigation" notice. The publisher has retracted 255, and nothing on the record says how the two counts connect.

Investigations

Three Sydney Space-Physics Papers Outlasted a 2023 Fabrication Finding Against Their First Author

A 2023 Sydney inquiry found Joachim Schmidt fabricated a figure in an unpublished manuscript. Journals now say figures in three of his published papers were likely fabricated too, and those retractions began with an anonymous complaint to the publisher in 2024.

Investigations

The Byline Broker Signed Its Sales Pitch With a London Oncologist's Name

Springer Journals Online sold co-author slots on papers it said were nearly through review at Elsevier, Wiley and Springer Nature, and signed the pitch with a cancer researcher's name. Its website is gone. The manuscripts have not been publicly identified.

Cancer

Nature Medicine Retracted the Lung Cancer Trial That Made Infusion Timing Look Like a Free Win

Its protocol was dated January 2022 but cited papers from 2024, and the editors called its survival curve smoother than a phase 3 trial should produce. A top journal published it anyway. The early-infusion claim is gone, but the body-clock question is still open.

Investigations

Physics of Fluids Sent a Postdoc's Name to the Authors Whose Algebra He Flagged

AIP Publishing tells its editors to protect the anonymity of anyone raising a concern. Physics of Fluids sent a postdoc's name, institution and rank to the authors he challenged, and 8 referees later found nothing to defend in their paper.

Investigations

The Zombie Papers: Retracted Stem-Cell Studies Still Feeding the Unproven-Cure Marketplace

A stem-cell paper retracted in November 2021 kept collecting citations for years, 72 by mid-2026, 27 of them after the notice went up, 15 since 2023 that never mention it. Two researchers counted, and named who is supposed to be cleaning up.

Investigations

'No Falsification': JAMA Keeps a Purdue-Funded Opioid Paper Its Own Retraction Rule Says to Pull

Court records from a 2007 federal case show Purdue had flagged 8 possible-withdrawal cases a year before its 2000 study called withdrawal rare. The journal says that isn't falsification, so the paper stays in print.

Investigations

NEJM Retracted the Study That Approved Amgen's Vasculitis Drug. It Had Never Done That in 200 Years.

The FDA says the drug's superiority result came from re-scoring nine patients after the trial was unblinded. It is still on U.S. shelves while Amgen fights the withdrawal.

Investigations

Retracted by Its Title: A Vaccine-SIDS Paper and a Standard That Isn't Science

A vaccine-safety paper sat in a peer-reviewed journal for five years, then was pulled in 2026 with a critic saying its title alone disqualified it. The science against the paper is strong; the retraction that followed wasn't science.

Investigations

A DC judge dismissed the Study 329 suit. The court did not say the paper is honest.

A DC court dismissed an attempt to force JAACAP and Elsevier to retract Study 329. The ruling did not find the paper sound. It found that no reader has standing to make a journal stop selling a fraudulent article.

Investigations

A Senate hearing finally put the cancer question on the record. The journal notice had been up for months.

Sen. Ron Johnson's June 3 subcommittee hearing on plausible mechanisms linking mRNA injections to cancer, the South Korean cohort behind it, and the editorial notice Springer had posted on the paper months earlier.

Investigations

Vietnam's New Integrity Rule Arrives 251 Retractions Late

Vietnam's Ministry of Science and Technology issued a research-integrity framework with permanent bans on May 25, 2026. The Retraction Watch database already lists 251 retractions carrying Vietnamese affiliations.